Andrew Nightingale PhD

Andrew has been a Bioinformatician with the Protein Function Development team at EMBL-EBI since 2012, and has a background in biochemistry and bioinformatics. Before joining EMBL-EBI, Andrew worked for a biotechnology company specialising in structure-based drug design by NMR. Andrew is responsible for enhancing the links between UniProt and the genomics and translational biology communities to provide clinical and/or translational context to UniProtKB.